Cypress Asset Management Inc Bristol Myers Squibb CO Transaction History

Cypress Asset Management Inc

  • $357 Million
  • Q1 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Feb 09, 2024
BUY
$57.89 - $64.73 $1.16 Million - $1.3 Million
20,069 New
20,069 $1.16 Million
Q2 2023

Aug 14, 2023
SELL
$63.71 - $70.74 $41,411 - $45,981
-650 Reduced 3.2%
19,684 $1.26 Million
Q1 2023

May 25, 2023
SELL
$65.71 - $74.53 $47,639 - $54,034
-725 Reduced 3.44%
20,334 $1.41 Million
Q4 2022

Feb 28, 2023
SELL
$68.48 - $81.09 $23,968 - $28,381
-350 Reduced 1.63%
21,059 $1.51 Million
Q3 2022

Nov 14, 2022
SELL
$0.13 - $76.84 $21 - $12,678
-165 Reduced 0.76%
21,409 $1.52 Million
Q2 2022

Aug 12, 2022
SELL
$72.62 - $79.98 $36,310 - $39,990
-500 Reduced 2.27%
21,574 $1.66 Million
Q1 2022

Jun 06, 2022
SELL
$61.48 - $73.72 $209,339 - $251,016
-3,405 Reduced 13.36%
22,074 $1.61 Million
Q4 2021

Jan 31, 2022
SELL
$53.63 - $62.52 $443,037 - $516,477
-8,261 Reduced 24.48%
25,479 $1.59 Million
Q3 2021

Oct 18, 2021
SELL
$59.17 - $69.31 $38,164 - $44,704
-645 Reduced 1.88%
33,740 $2 Million
Q2 2021

Aug 06, 2021
SELL
$61.91 - $67.42 $253,335 - $275,882
-4,092 Reduced 10.63%
34,385 $2.3 Million
Q1 2021

Apr 22, 2021
SELL
$59.34 - $66.74 $328,446 - $369,405
-5,535 Reduced 12.58%
38,477 $2.43 Million
Q4 2020

Feb 10, 2021
BUY
$57.74 - $65.43 $188,232 - $213,301
3,260 Added 8.0%
44,012 $2.73 Million
Q3 2020

Oct 26, 2020
BUY
$57.43 - $63.64 $431,586 - $478,254
7,515 Added 22.61%
40,752 $2.46 Million
Q2 2020

Jul 28, 2020
BUY
$54.82 - $64.09 $222,404 - $260,013
4,057 Added 13.9%
33,237 $1.95 Million
Q1 2020

May 07, 2020
BUY
$46.4 - $67.43 $77,024 - $111,933
1,660 Added 6.03%
29,180 $1.63 Million
Q4 2019

Feb 06, 2020
BUY
$49.21 - $64.19 $171,988 - $224,344
3,495 Added 14.55%
27,520 $1.77 Million
Q3 2019

Oct 21, 2019
SELL
$42.77 - $50.71 $50,254 - $59,584
-1,175 Reduced 4.66%
24,025 $1.22 Million
Q2 2019

Aug 13, 2019
BUY
$44.62 - $49.34 $441,738 - $488,466
9,900 Added 64.71%
25,200 $1.14 Million
Q1 2019

Apr 29, 2019
SELL
$45.12 - $53.8 $385,099 - $459,183
-8,535 Reduced 35.81%
15,300 $730,000
Q4 2018

Feb 12, 2019
SELL
$48.76 - $63.23 $83,623 - $108,439
-1,715 Reduced 6.71%
23,835 $1.24 Million
Q3 2018

Oct 19, 2018
SELL
$55.19 - $62.25 $143,218 - $161,538
-2,595 Reduced 9.22%
25,550 $1.59 Million
Q2 2018

Jul 27, 2018
SELL
$50.53 - $62.98 $505,097 - $629,548
-9,996 Reduced 26.21%
28,145 $1.56 Million
Q1 2018

May 14, 2018
SELL
$59.92 - $68.98 $713,467 - $821,344
-11,907 Reduced 23.79%
38,141 $2.41 Million
Q4 2017

Jan 31, 2018
SELL
$59.94 - $65.35 $123,836 - $135,013
-2,066 Reduced 3.96%
50,048 $3.07 Million
Q3 2017

Nov 08, 2017
BUY
$55.23 - $63.74 $2.88 Million - $3.32 Million
52,114
52,114 $3.32 Million

Others Institutions Holding BMY

# of Institutions
2,425
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cypress Asset Management Inc Portfolio

Follow Cypress Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email